Skip to content
akaturk Academic measurement

Article detail · 2023 · article

Incidence of cereblon protein in intensive care patients: a cross-sectional study.

Journal Eur Rev Med Pharmacol Sci. The ISSN points to another catalog journal; the name is from the YÖKSİS record.
ISSN2284-0729
YÖKSİS OpenAlex
Year2023
Citations1OpenAlex
Percentile%40.5
FWCI0.091.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q2

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueEur Rev Med Pharmacol Sci.
  • Catalog match (ISSN)European Review for Medical and Pharmacological Sciences (discontinued)
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

OBJECTIVE: Sepsis remains a common cause of death. The cereblon (CRBN) protein, which is involved in important cellular processes, plays a role in sepsis. This cross-sectional study aimed to show the CRBN protein expression and its effects on patients in the intensive care unit. PATIENTS AND METHODS: Samples were taken by deep tracheal aspiration from patients. The presence of CRBN was pathologically investigated using immunohistochemical tests and polyclonal antibodies against CRBN. The relationship between gender, sepsis, steroid, survival and the presence of CRBN was examined. RESULTS: Respiratory and neurologic diseases were the most common reasons for admission. Acinetobacter was the most frequent microorganism. In patients with more than normal inflammatory cells, a negative correlation was observed between CRBN expression and leukocyte rate (p=0.031). In patients with CRBN, there was no correlation between steroid and mortality, APACHE/Glasgow score, hospital stay length, and ICU. CONCLUSIONS: Although the prognosis for sepsis is better in CRBN-deficiency animals, the presence of CRBN in humans does not affect it. In our study, CRBN decreased as inflammatory cells increased in the patient's aspiration material. The response to steroids, an immunomodulator, did not change with the presence of the immunomodulator target molecule, CRBN. Therefore, using immunomodulators in the treatment of sepsis should be reconsidered.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

1citationsOpenAlex · cited_by_count (cache / database)

Authors

8
  1. PINAR AYVAT 1
  2. AYŞE GÜLDEN DİNİZ ÜNLÜ İZMİR DEMOKRASİ ÜNİVERSİTESİ 2
  3. HAKAN GÜLMEZ 3
  4. DERYA ARSLAN YURTLU 4
  5. Kamil Aşar 5
  6. KAAN KATIRCIOĞLU 6
  7. CEM ECE 7
  8. ZEYNEP SOFUOĞLU İZMİR DEMOKRASİ ÜNİVERSİTESİ 8